Statistics

Total Visits

Views
Cabazitaxel in patients with advanced CRPC after Docetaxel-Failure. Results of expanded Program access(EAP) in Spain: Safety and efficacy.69

Select a period of time:

Number of views in the range

Views
Cabazitaxel in patients with advanced CRPC after Docetaxel-Failure. Results of expanded Program access(EAP) in Spain: Safety and efficacy.28

Views

Views
September 20250
October 20251
November 20259
December 20253
January 202610
February 20263
March 20262
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States16
Brazil6
Germany2
Finland1
United Kingdom1
Mexico1
Venezuela1
 

Top cities views

Views
San Jose8
Ashburn6
Frankfurt am Main2
Barbacena1
Belo Horizonte1
Grajales1
Helsinki1
Iporá1
Itabira1
Marmelópolis1